← Leaderboards
Cielito C Reyes-Gibby
University Of Tx Md Anderson Can Ctr
$3,873,330
Attributed
$6,919,530
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $710.8K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,919,530 · 5
By mechanism
R01$5,639,317 · 2
K07$673,129 · 1
R21$453,084 · 1
R03$154,000 · 1
Top collaborators
- Sanjay Shete8 shared
- Sai-Ching Jim Yeung4 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Paul A Scheet$7,895,863
- Wendy A Woodward$3,444,065
- Abenaa M Brewster$1,367,215
- Chad Daniel Huff$10,145,666
- Eduardo Vilar Sanchez$16,310,319
Others in their field
Top investigators on “Epidemiology”
- David Heimbrook · Leidos Biomedical Research, Inc.$390,770,069
- George R Seage · Abt Associates, Inc.$299,251,523
- Jeffrey P Krischer · University Of South Florida$264,076,260
- Barbara Driver · Westat, Inc.$221,167,491
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$206,739,528
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
EpidemiologySamplingCancer TherapySeveritiesBasePainMultidisciplinaryNewly DiagnosedCancer CenterMolecular GeneticsGenesGeneticResponseBiologicalCohort StudiesStagingSymptomsReportingMalignant NeoplasmsChemotherapyCancer PatientInflammationHigh RiskOperative Surgical Procedures
Grant awards (19)
Improving emergency care and outcomes of immune-related adverse events: The immune-related emergency disposition index (IrEDi)$663,212
R01 · FY2025 · CA · contact PI
Improving emergency care and outcomes of immune-related adverse events: The immune-related emergency disposition index (IrEDi)$629,751
R01 · FY2024 · CA · contact PI
Improving emergency care and outcomes of immune-related adverse events: The immune-related emergency disposition index (IrEDi)$648,983
R01 · FY2023 · CA · contact PI
Improving emergency care and outcomes of immune-related adverse events: The immune-related emergency disposition index (IrEDi)$709,427
R01 · FY2022 · CA · contact PI
Composition and temporal changes of the oral microbiome in head and neck cancer patients at high risk for oral mucositis$199,042
R21 · FY2019 · DE · contact PI
Composition and temporal changes of the oral microbiome in head and neck cancer patients at high risk for oral mucositis$254,042
R21 · FY2018 · DE · contact PI
Molecular Epidemiology of Neuropathic Pain in Head and Neck Cancer$635,623
R01 · FY2016 · DE · contact PI
Molecular Epidemiology of Neuropathic Pain in Head and Neck Cancer$689,299
R01 · FY2015 · DE · contact PI
Molecular Epidemiology of Neuropathic Pain in Head and Neck Cancer$533,247
R01 · FY2014 · DE · contact PI
Molecular Epidemiology of Neuropathic Pain in Head and Neck Cancer$177,515
R01 · FY2014 · DE · contact PI
Molecular Epidemiology of Neuropathic Pain in Head and Neck Cancer$466,413
R01 · FY2013 · DE · contact PI
Molecular Epidemiology of Neuropathic Pain in Head and Neck Cancer$485,847
R01 · FY2012 · DE · contact PI
Cytokine Polymorphisms and Cancer Related Pain$77,000
R03 · FY2009 · CA · contact PI
Gene Polymorphism & Treatment-Symptoms in Lung Cancer$138,197
K07 · FY2008 · CA · contact PI
Cytokine Polymorphisms and Cancer Related Pain$77,000
R03 · FY2008 · CA · contact PI
Gene Polymorphism & Treatment-Symptoms in Lung Cancer$137,054
K07 · FY2007 · CA · contact PI
Gene Polymorphism & Treatment-Symptoms in Lung Cancer$136,171
K07 · FY2006 · CA · contact PI
Gene Polymorphism &Treatment-Symptoms in Lung Cancer$132,591
K07 · FY2005 · CA
Gene Polymorphism &Treatment-Symptoms in Lung Cancer$129,116
K07 · FY2004 · CA